TY  - GEN
AU  - Littlepage,Laurie E
AU  - Adler,Adam S
AU  - Kouros-Mehr,Hosein
AU  - Huang,Guiqing
AU  - Chou,Jonathan
AU  - Krig,Sheryl R
AU  - Griffith,Obi L
AU  - Korkola,James E
AU  - Qu,Kun
AU  - Lawson,Devon A
AU  - Xue,Qing
AU  - Sternlicht,Mark D
AU  - Dijkgraaf,Gerrit J P
AU  - Yaswen,Paul
AU  - Rugo,Hope S
AU  - Sweeney,Colleen A
AU  - Collins,Colin C
AU  - Gray,Joe W
AU  - Chang,Howard Y
AU  - Werb,Zena
TI  - The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression
SN  - 2159-8290
PY  - 2012///1217
KW  - Animals
KW  - Antibiotics, Antineoplastic
KW  - pharmacology
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Blotting, Western
KW  - Breast Neoplasms
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Disease Progression
KW  - Doxorubicin
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - MCF-7 Cells
KW  - Mice
KW  - NIH 3T3 Cells
KW  - Neoplastic Stem Cells
KW  - metabolism
KW  - Oligonucleotide Array Sequence Analysis
KW  - Prognosis
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Ribonucleosides
KW  - Survival Analysis
KW  - Trans-Activators
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/2159-8290.CD-12-0093
ER  -